Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis.

Jacques-Olivier Pers; Juliette Coat; Julien Demoersman; Divi Cornec; Valérie Devauchelle-Pensec; Alain Saraux

Conference Papers Year : 2016

Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis.

(1) , (1) , (1) , (2, 1) , (1, 2) , (1, 2)

1
2

Jacques-Olivier Pers

Function : Author
PersonId : 753610
IdHAL : jacques-olivier-pers
ORCID : 0000-0001-7287-5541
IdRef : 068262159

Immunologie et Pathologie

Juliette Coat

Function : Author

Immunologie et Pathologie

Julien Demoersman

Function : Author

Immunologie et Pathologie

Divi Cornec

Function : Author
PersonId : 766860
ORCID : 0000-0002-9159-702X

CHRU Brest - Service de Rhumatologie

Immunologie et Pathologie

Valérie Devauchelle-Pensec

Function : Author
PersonId : 766858
ORCID : 0000-0003-0432-825X

Immunologie et Pathologie

CHRU Brest - Service de Rhumatologie

Alain Saraux

Function : Author
PersonId : 762362
ORCID : 0000-0002-8454-7067

Immunologie et Pathologie

CHRU Brest - Service de Rhumatologie

Domains

Immunology

Geneviève Michel : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-01296598

Submitted on : Friday, April 1, 2016-11:36:59 AM

Last modification on : Friday, November 29, 2024-5:29:27 PM

Dates and versions

hal-01296598 , version 1 (01-04-2016)

Identifiers

HAL Id : hal-01296598 , version 1

Cite

Jacques-Olivier Pers, Juliette Coat, Julien Demoersman, Divi Cornec, Valérie Devauchelle-Pensec, et al.. Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis. . 10th International Congress on Autoimmunity , Apr 2016, Leipzig, Germany. ⟨hal-01296598⟩

Rituximab immunotherapy is associated with improvement of periodontal in subjects with rheumatoid arthritis.

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Share